Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia

Aravind Krishnan, Alejandro Suarez-Pierre, Todd C. Crawford, Xun Zhou, Stuart D. Russell, Ronald D. Berger, Hugh Calkins, William A. Baumgartner, Harikrishna Tandri, Kaushik Mandal

Research output: Contribution to journalArticlepeer-review

Abstract

We describe the novel use of bilateral cardiac sympathectomy in a woman with end-stage heart failure caused by ventricular tachycardia refractory to standard medical therapy who was under consideration for heart transplantation. Postoperatively, our patient has not experienced any symptoms of ventricular tachycardia, has returned to normal physical activity, and is no longer under consideration for transplantation as a result of the improvement in her cardiac function. Bilateral sympathectomy can be more effective than unilateral sympathectomy or percutaneous stellate ganglion blockade in patients with refractory ventricular tachycardia. Careful patient selection is necessary to identify patients who will benefit most from the procedure.

Original languageEnglish (US)
Pages (from-to)e51-e53
JournalAnnals of Thoracic Surgery
Volume105
Issue number2
DOIs
StatePublished - Feb 2018

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Sympathectomy for Stabilization of Heart Failure Due to Drug-Refractory Ventricular Tachycardia'. Together they form a unique fingerprint.

Cite this